This review article discusses the protective effects of extra virgin olive oil (EVOO) on cardiovascular diseases (CVDs). The authors focus on the two major bioactive components of EVOO: oleic acid (OA) and polyphenols. They explore the mechanisms by which these components exert their beneficial effects, encompassing impacts on oxidative stress, inflammation, blood pressure, endothelial function, cholesterol levels, and the intestinal microbiota.
Oleic Acid (OA):
- Lowering Blood Lipid Levels: OA, a monounsaturated fatty acid (MUFA) comprising 70-80% of EVOO, has been shown to reduce plasma total cholesterol (TC), very low-density lipoprotein (VLDL), and low-density lipoprotein (LDL) cholesterol. . This is achieved by inhibiting hepatic LDL receptor activity, plasma cholesteryl ester transfer protein (CETP) activity, and hepatic HMG-CoA reductase activity. OA also increases high-density lipoprotein (HDL) cholesterol levels . One study cited reported a reduction in triglycerides and an increase in HDL with OA substitution . Another study in rats showed that an OA-rich diet decreased plasma LDL and triglycerides while potentially increasing HDL. It also suggested limited utilization of OA in adipose tissue synthesis . A human trial showed that a high OA oil diet (19.1% MUFAs, 7% PUFAs, and 6.4% saturated fatty acids) resulted in lower TC, LDL, ApoB, and non-HDL cholesterol, as well as improved TC:HDL and ApoB:ApoA1 ratios, compared to a control diet (10.5% MUFAs, 10% PUFAs, and 12.3% saturated fatty acids) .
- Inhibiting Postprandial Reflex Effects: OA improves postprandial blood pressure control, potentially by influencing cell membrane structure and physiology, impacting G-protein docking with signaling proteins. Studies suggest that OA intake alters membrane lipid and G-protein levels, contributing to hypotensive effects . OA's influence on the cell membrane, particularly its promotion of the non-lamellar phase and reduction of phospholipid head group accumulation, affects the distribution of G-protein subunits, which are involved in blood pressure regulation. OA also promotes vasodilator secretion and inhibits vasoconstrictor release .
- Protecting Vascular Endothelial Function: OA protects against postprandial vascular endothelial dysfunction caused by fat deposition and oxidative stress . It increases nitric oxide (NOX) bioavailability, leading to a stronger endothelium-mediated vasodilatory response compared to diets rich in saturated fatty acids or alpha-linolenic acid. OA also mitigates oxidative stress and the postprandial inflammatory response by inhibiting the NF-κB signaling pathway .
- Alleviating Insulin Resistance and Atherosclerosis: OA reduces insulin resistance by inhibiting IRS1 serine phosphorylation while inducing its tyrosine phosphorylation, thus activating the PI3K pathway and enhancing insulin sensitivity . In vascular smooth muscle cells (VSMCs), OA modulates NF-κB to reduce insulin resistance and the expression of inflammatory factors like IL-6 and TNF-α. It also inhibits VSMC proliferation induced by angiotensin II, palmitate, or TNF-α, thus limiting atherosclerotic plaque growth. Additionally, OA attenuates TNF-α-induced PAI-1 expression in VSMCs, slowing thrombosis and fibrinolysis .
Polyphenols:
- Inhibiting Oxidative Stress: Polyphenols exhibit potent antioxidant properties. Hydroxytyrosol (HT), a key polyphenol in EVOO, prevents increased reactive oxygen species (ROS) production. HT activates AMPK, which in turn activates FOXO3a, leading to increased expression of antioxidant enzymes like manganese superoxide dismutase, catalase, and thioredoxin . HT also promotes Nrf2 nuclear translocation through the PI3K/AKT and ERK1/2 pathways, activating heme oxygenase-1 (HO-1) and further inhibiting oxidative stress while enhancing vascular endothelial cell proliferation and repair .
- Inhibiting Inflammatory Response: Polyphenols, particularly HT, exert anti-inflammatory effects by regulating the NF-κB pathway . They inhibit the activation of NF-κB, I-κBα, and STAT-1α, thus reducing the expression of inflammatory factors. Oleuropein, a secoiridoid found in EVOO, plays a role in regulating MMP9 . HT inhibits the LPS-induced increase in ROS and COX-2 activation, reducing COX-2 expression and MMP9 activity at pre-translational levels . This inhibitory effect is mediated by interference with early signaling cascade steps, including the inhibition of classical PKC activation. HT also reduces PGE2 and COX-2 expression, and MMP9 concentration in peripheral monocytes . Studies have shown EVOO consumption reduces plasma levels of inflammatory markers like IL-5, IL-6, IL-7, IL-8, MCP-1, TNF-α, and IFN-γ while increasing atherosclerotic stability . VOO intake also reduces postprandial inflammatory response and proinflammatory gene expression by decreasing the activation of NF-kB, AP-1, cytokines, MAPKs, and the arachidonic acid pathway, and by reducing intestinal absorption of LPS after high-fat meals .
- Regulating LDL Level: Polyphenols improve oxidative status, which is linked to higher lipoprotein lipase (LPL) activity. They decrease small, dense LDL particles, which are highly atherogenic . One study reported a 15.3% depletion of small LDL particles after polyphenol consumption .
- Regulating HDL Level: EVOO polyphenols increase HDL levels in a dose-dependent manner . They promote the formation of larger, more mature HDL particles, increasing HDL size and large HDL quantity while decreasing small HDL. These changes enhance cholesterol efflux capacity, LCAT, and CETP activities, as well as antioxidant, anti-inflammatory, and vasodilatory capacities. Polyphenols also modulate the PON family of enzymes, particularly increasing PON3 activity, which is beneficial in CVDs . They improve the antioxidant environment for ApoA-I, which activates ABCA1, a protein crucial for HDL production and cholesterol reverse transport .
- Protecting Vascular Endothelial Function: Polyphenols enhance endothelial function, crucial for vascular health. HT increases NO production through redox-sensitive activation of the PI3K/AKT pathway, leading to eNOS activation . HT also stimulates eNOS phosphorylation at Ser1177 via p38, ERK, and AKT pathways. It reduces iNOS expression in monocytes . HT further contributes to endothelium-dependent vasodilation by activating cGMP .
- Relieving Hypertension: EVOO polyphenols lower blood pressure by decreasing serum ADMA concentration and increasing NO utilization . They restore endothelial function, leading to antihypertensive effects, particularly in individuals with endothelial damage and hypertension . Oleuropein, which is hydrolyzed to HT in the gastrointestinal tract, also contributes to blood pressure reduction . HT increases plasma nitrate and nitrite levels, key NO donors, and inhibits endothelin-1 expression, a potent vasoconstrictor .
Intestinal Microbiota:
EVOO, through its polyphenols, interacts with the gut microbiota, impacting CVD risk. Complex polyphenols are hydrolyzed to simpler forms like tyrosol and HT, which can be metabolized by gut bacteria. Oleuropein, for example, is catabolized to HT, then further broken down to 2-(3’,4’-dihydroxyphenyl) acetic acid, and eventually to 2-(4’-hydroxyphenyl) acetic acid and phenylacetic acid. Tyrosol is oxidized to 2-(4’-hydroxyphenyl) acetic acid . Polyphenols act as prebiotics, promoting the growth of beneficial bacteria like Bifidobacterium and Lactobacillus. These probiotics exert antioxidant and anti-inflammatory effects, protect intestinal barrier function, inhibit pro-inflammatory factor production (TNF-α, IL-6), promote mucin production, and lower LDL and TC levels . Probiotics have also been associated with antihypertensive effects by inhibiting angiotensin-converting enzyme. EVOO consumption promotes the growth of Bacteroides, which reduce LPS circulation, decrease intestinal permeability, and inhibit endotoxemia and inflammatory responses, thereby protecting against CVDs . Polyphenols can also inhibit the growth of harmful bacteria like Escherichia coli . Studies have demonstrated the prebiotic activity of polyphenol-rich OO, increasing Bifidobacterium and polyphenol metabolites with antioxidant activity, resulting in lower LDL levels .
The authors conclude that EVOO, through its OA and polyphenol components, offers significant cardiovascular protection via multiple mechanisms. Further research is needed to fully elucidate the biological activities of EVOO's diverse phenolic compounds and to conduct well-designed clinical trials to confirm its health benefits in CVDs.




